2015 Antineoplastics

PROCESSES TARGETED BY ANTINEOPLASTIC DRUGS
listed (in broad terms) from least to most specific

  1. Rapid cell growth (cytotoxic drugs)

  2. Angiogenesis/metastasis

  3. Lack of differentiation

  4. Cell surface markers / Lack of immune response

  5. Defective gene products

Note: there are NO DRUGS that correct the underlying genetic and/or epigenetic defects responsible for any type of cancer.

Email: Dr. Janet Fitzakerley | ©2015 University of Minnesota Medical School Duluth | Last modified: 11-apr-15 9:39 AM